niacinamide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

niacinamide has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beattie, GM; Cirulli, V; Hayek, A; Lopez, A; Mally, MI; Ptasznik, A1
Chang, CC; Ferber, S; Linning, KD; Madhukar, BV; Olson, LK; Reed, DN; Tai, MH; Trosko, JE1
Arribas, MI; Jones, J; Leon-Quinto, T; Roche, E; Soria, B1
Flaherty, KT; Garbe, C; Kulms, D; Lasithiotakis, KG; Maczey, E; Meier, FE; Schittek, B; Sinnberg, TW1
Cohen, L; Gao, Y; Gu, K; Li, HX; Meng, ZQ; Wang, P; Xu, LT; Xu, LY; Yang, PY1
Doudican, NA; Orlow, SJ; Quay, E; Zhang, S1
Corey, SJ; Park, BJ; Whichard, ZL1
Dekervel, J; Nevens, F; Van Cutsem, E; van Malenstein, H; van Pelt, J; Verslype, C; Windmolders, P1
Cai, JB; Dong, ZR; Fan, J; Gao, DM; Gao, PT; Hu, ZQ; Huang, XY; Ke, AW; Li, KS; Shen, YH; Shi, GM; Tian, MX; Zhang, C; Zhang, PF1

Reviews

1 review(s) available for niacinamide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

ArticleYear
Role of small bioorganic molecules in stem cell differentiation to insulin-producing cells.
    Bioorganic & medicinal chemistry, 2006, Oct-01, Volume: 14, Issue:19

    Topics: Alkaloids; Androstadienes; Animals; Butyrates; Cell Differentiation; Chromones; Enzyme Inhibitors; Glucose; Humans; Insulin; Insulin Antagonists; Morpholines; Niacinamide; Stem Cells; Tretinoin; Wortmannin

2006

Other Studies

8 other study(ies) available for niacinamide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

ArticleYear
Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation.
    The Journal of cell biology, 1997, Jun-02, Volume: 137, Issue:5

    Topics: Androstadienes; Cell Differentiation; Cell Division; Chromones; DNA; Enzyme Inhibitors; Fetus; Glucagon; Hepatocyte Growth Factor; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Morpholines; Niacinamide; Pancreas; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Somatostatin; Wortmannin

1997
Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential.
    Pancreas, 2004, Volume: 29, Issue:3

    Topics: Acetylcysteine; Adenoviridae; Adult; Albumins; alpha-Amylases; C-Peptide; Cell Aggregation; Cell Differentiation; Cell Separation; Cells, Cultured; Chromones; Culture Media; Culture Media, Serum-Free; Exenatide; Gene Expression Regulation; Genetic Vectors; Glucagon; Homeodomain Proteins; Humans; Insulin; Intermediate Filament Proteins; Intracellular Fluid; Islets of Langerhans; Morpholines; Nerve Tissue Proteins; Nestin; Niacinamide; Oxidation-Reduction; Peptides; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Stem Cells; Trans-Activators; Transcription Factors; Venoms; Vimentin

2004
Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.
    The Journal of investigative dermatology, 2008, Volume: 128, Issue:8

    Topics: Androstadienes; Apoptosis; Benzenesulfonates; Butadienes; Cell Line, Tumor; Cell Proliferation; Chromones; Down-Regulation; Flavonoids; Humans; Mechanistic Target of Rapamycin Complex 1; Melanoma; Mitogen-Activated Protein Kinase Kinases; Morpholines; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Invasiveness; Niacinamide; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-bcl-2; Pyridines; Signal Transduction; Sirolimus; Skin Neoplasms; Sorafenib; TOR Serine-Threonine Kinases; Transcription Factors; Wortmannin

2008
Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK.
    Molecular biology reports, 2012, Volume: 39, Issue:2

    Topics: Antineoplastic Agents; Benzenesulfonates; Blotting, Western; Bufanolides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Synergism; Gene Expression Regulation, Enzymologic; Humans; Liver Neoplasms; Microscopy, Electron, Transmission; Morpholines; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib

2012
Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways.
    Anticancer research, 2011, Volume: 31, Issue:10

    Topics: Anthracenes; Benzenesulfonates; Cell Death; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Melanoma; Morpholines; Niacinamide; Phenylurea Compounds; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Sorafenib

2011
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.
    Cancer letters, 2012, Jul-01, Volume: 320, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Breast Neoplasms; Butadienes; Cell Line, Tumor; Chromones; Dasatinib; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epothilones; Female; Humans; Morpholines; Niacinamide; Nitriles; Paclitaxel; Phenylurea Compounds; Pyridines; Pyrimidines; Signal Transduction; Sirolimus; Sorafenib; Tamoxifen; Thiazoles

2012
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth.
    Cancer letters, 2013, Feb-01, Volume: 329, Issue:1

    Topics: Anilides; Antineoplastic Agents; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromones; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Keratin-19; Liver Neoplasms; Morpholines; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Pyridines; Sorafenib; Vimentin

2013
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.
    Cell death & disease, 2016, Apr-21, Volume: 7

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Focal Adhesion Kinase 1; Galectin 1; Humans; Integrin alphaVbeta3; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Morpholines; Neoplasm Invasiveness; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; Sorafenib; Survival Rate

2016